|
RTOG Web-Based Registration and Data Collection Manual
- 0012 Phase II Rectal Follow-up (F1)
- 0113 Esophagus Follow-up (F1)
- 0114 Gastric Follow-up (F1)
- 0116 Phase II Cervix Follow-up (F1)
- 0126 Prostate Follow-up (F1)
- 0128 Cervix - Follow up (F1)
- 0129 Head and Neck Follow-up (F1)
- 0246 Esophagus Follow-up (F1)
- 0247 Rectal Follow-up (F1)
- 0319 Breast Follow-up (F1)
- 0320 Phase III Brain Follow-up (F1)
- 0415 Phase III Prostate Follow-up (F1), Initial Evaluation (I1), Radiotherapy Form (T1)
- 0417 Cervix Follow-up (F1), Initial Evaluation (I1)
- 0418 Phase II IMRT Radiotherapy Form(T1), Phase II Cx/Endo Follow-up (F1), Initial Evaluation (I1), Treatment Summary (TF)
- 0424 Phase II Brain Follow-up (F1)
- 0436 Phase III Esophagus Initial Evaluation (I1), Radiotherapy (T1), Post Treatment Response (F2)
- 0438 Phase I Liver Follow-up (F1)
- 0513 Phase I/II GBM Initial Evaluation(I1), Follow-up Form (F1)
- 0521 Radiotherapy Form (T1) ,Initial Follow-up (F0), Interim Follow Up (FS), Follow-up (F1), Initial Evaluation (I1)
- 0522 Advanced H & N Follow-up (F1), Radiotherapy Form (T1)
- 0525 Brain GBM all forms
- 0526 Phase II Prostate Brachy Initial Evaluation (I1), Followup Form (F1)
- 0529 Phase II Anal Canal Follow-up (F1), Initial Evaluation (I1), Post Treatment Response (F2), Radiotherapy (T1)
- 0534 Interim Follow-up Form (F0),Phase III Prostate Follow-up (F1), Initial Evaluation (I1), Radiotherapy Form (T1)
- 0611 GBM VEGF/MMP Follow-up (F1), Initial Evaluation (I1)
- 0614 Phase III Memantine/Placebo/WBRT Initial Evaluation (I1), Follow-up (F1), Treatment Summary (TF), Radiotherapy Form(T1)
- 0615 Phase II Nasopharyngeal Radiotherapy Form (T1)
- 0617 Phase III NSCLC Initial Evaluation (I1), Phase III NSCLC Followup Form (F1), Treatment Summary Form (TF), Radiotherapy Form (T1)
- 0618 Phase II SBRT Initial Evaluation (I1), Radiotherapy Form (T1)
- 0621 Phase II Prostate Initial Evaluation (I1), Phase II Prostate Radiotherapy (T1)
- 0622 Phase II Prostate Samarium Initial Evaluation (I1)
- 0623 Phase II SCLC Initial Evaluation (I1), Radiotherapy Form (T1)
- 0627 Phase II GBM Follow-up (F1), Initial Evaluation (I1)
- 0630 Phase III Sarcoma Initial Evaluation (I1), Radiotherapy(T1)
- 0822 Phase II Rectal Initial Evaluation Form(I1), Follow Up Form(F1), Surgery Form (S1), Post-op Treatment Summary Form (SF), Pre-op Treatment Summary Form (TF)
- 8531 Phase III Prostate Follow-up (F1)
- 9202 Phase III Prostate Follow-up (F1)
- 9406 Prostate Follow-up (F1)
- 9408 Prostate Follow-up (F1)
- 9413 Prostate Follow-up (F1)
- 9601 Prostate Follow-up (F1)
- 9704 Pancreas Follow-up (F1)
- 9804 DCIS Breast Follow-up (F1)
- 9811 Anal Canal Follow-up (F1)
- 9904 Follow-up Form (F1)
- 9910 Prostate Follow-up (F1)
PRACTICE
RTOG - Pilot (Study - 9998)
ACTIVE STUDIES
RTOG Protocols
In the near future RTOG will embark on an initiative to activate Web registration for a number of its studies. In preparation for this event, we would like to provide some vital information which will assist you to determine if your site is appropriately equipped to participate in this new Web service.
In order to use the Web Registration module successfully, all participating sites must meet the minimum system requirements as indicated below:
- Pentium III or greater processor with minimum 128 MB RAM.
- Microsoft Windows 98, 2000 or XP.
- Free Hard Drive Storage space 100 MB.
- Video card with 2 MB of RAM for minimum 16 bit (High Color) display
- Internet Explorer version 6.0 or above installed.
- Netscape Navigator 7.1.
Attached you will find two (2) documents that deal with the Internet Explorer and Netscape Navigator browser settings that have to be changed to meet our requirements.
Please take this opportunity to contact your local IT support staff to resolve any problems that may relate your ability to utilize this service.
- IE Browser Settings
- Navigator Browser Settings
|
 |
If you would like to utilize Web Registration site to register a patient and have not been assigned a user name and password from RTOG Headquarters, please access the Password Authorization Form from the link provided.
You must fill this form out completely and have it signed by the member institution Principal Investigator. All forms should be faxed to RTOG Headquarters at (215) 928-0153.
- RTOG Password Authorization Form
- 0123 - CAPTOPRIL FOR SMALL OR NONSMALL LUNG CANCER
- 0126 - PROSTATE:3D
- 0214 - LUNG: PCI FOR NON-SMALL CELL CARCINOMA
- 0227 - PHASE I/II
- 0229 - NEOADJ TX LA NSCLC
- 0232 - PROSTATE: BRACHYTHERAPY +/- EXT. BEAM RT
- 0235 - NSCLC PET STAGING AND ASSESSMENT (ACRIN 6668)
- 0244 - HEAD & NECK: SALIVARY GLAND TRANSFER
- 0320 - BRAIN METS: WBRT, SRS VS. WBRT, SRS W/WO TEMODAR, ERLOTINIB
- 0415 - PHASE III RANDOMIZED HYOFRACTIONATION VS RT IN LOCALIZED PROSTATE CANCER
- 0417 - Phase II CERVIX/BEVACIZUMAB
- 0418 - IMRT FOR POSTOP ENDOMETRIAL/CERVIX
- 0424 - PHASE II BRAIN
- 0436 - PHASE III ESOPHAGUS
- 0438 - EXTRACRANIAL 3DCRT UNRESECTABLE LIVER METASTASES
- 0513 - GBM:RS, MOTEXAFIN GADOLINIUM + TEMOZOLOMIDE
- 0514 - HEAD AND NECK TISSUE BANK
- 0517 - PALLIATION BONE METS
- 0518 - PROSTATE: OSTEOPOROSIS RISK
- 0521 - PROSTATE:CONFORMAL RT PLUS ANDROGEN ABLATION/HIGH RISK
- 0522 - ADVANCED UNRESECTED H & N
- 0524 - BLADDER CANCER: SURGERY+PACLITAXEL, TRASTUZUMAB, AND RT
- 0525 - GBM: RT/TMZ + CONVENTIONAL TMZ VS RT/TMZ + DOSE-INTENSIVE TMZ
- 0526 - PHASE II PROSTATE/BRACHY
- 0534 - PHASE III PROSTATE
- 0611 - URINARY VEGF & MMP LEVELS POST-RT IN PTS WITH GBM
- 0612 - PROSTATE DNA MICROARRAY
- 0615 - PHASE II NASOPHARYNGEAL
- 0617 - PHASE III NSCLC Radiotherapy
- 0621 - Phase II Prostate Radiotherapy
- 0622 - Phase II Prostate Samarium
- 0623 - PHASE II SCLC
- 0625/ACRIN6677 - PHASE II GMB
- 0627 - PHASE II GBM
- 0630 - PHASE II SARCOMA
- 0822 - PHASE II RECTAL
|
